ÂÜÀòÂÒÂ×

Sreeram Reddy is an experienced professional in the biotechnology and pharmaceutical sectors, currently serving as Vice President of Growth Strategy at ApotheCom, an Inizio Company, since October 2024. Prior to this role, Sreeram Reddy held various positions at Vaniam Group, including Senior Director of Clinical Strategy, where significant contributions included developing growth strategies that resulted in a substantial increase in revenue. Previous experiences also include Director of Business Strategy at DAVA Oncology, Project Manager at Mentrik Biotech, and Research Associate at Caliber Biotherapeutics. Sreeram Reddy's educational background includes a Bachelor of Science in Biology and a Master's in Biotechnology, both from Texas A&M University.